Deutsche Aircraft and Pratt & Whitney Canada Advance Regional Turboprop Innovation at Paris Air Show
Notified -
Globe Newswire18-06-2025, 19:13
Io Therapeutics, Inc., presented today results from studies of IRX4204, the company’s phase II clinical development stage, highly selective RXR nuclear receptor agonist compound, supporting its potential use for treatment of amyotrophic lateral sclerosis 16-07-2024, 20:26
